1. Mitsuoka T. The human gastroinstestinal tract. In: Brian JB Wood, ed. In: Lactic Acid Bacteria, Vol. 1. London and New York: Wood Publisher Elseivier Applied Science, 1992:69-114.

2. Hoskins LC. Mucin degradation in the human gastrointestinal tract and its significance to enteric microbial ecology. Eur J Gastroenterol Hepatol 1993; 5:205.

3. Bry L, Falk PG, Midtvedt T, Gordon JI. A model of host-microbial interactions in an open mammalian ecosystem. Science 1996; 273:1380-1383.

4. Ross MH, Kaye GI, Pawlina W. Digestive system III: esophagus and gastrointestinal tract. Histology: A Text and Atlas. Philadelphia: Lippincott Williams & Wilkins, 2003 pp. 474-531.

5. Gartner LP, Hiatt JL. Digestive system III— alimentary canal. Color Textbook of Histology. Philadelphia: W.B. Saunders Company, 1997 pp. 325-335.

6. Junqueria LC, Carneiro J, Contopoulos AN. Digestive tract. In: Junqueria LC, Carneiro J, Contopoulos AN, eds. Basic Histology: Text and Atlas. Los Altos. CA: Lange Medical Publications, 1998 pp. 272-303.

7. Allen A, Carroll NJ. Adherent and soluble mucus in the stomach and duodenum. Dig Dis Sci 1985; 30:55S-62S.

8. Forstner JF, Oliver MG, Sylvester FA. Production, structure, and biologic relevance of gastrointestinal mucins. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the Gastrointestinal Tract. New York: Raven Press, 1995:71-88.

9. Belley A, Keller K, Gottke M, Chadee K, Gottke M. Intestinal mucins in colonization and host defense against pathogens. Am J Trop Med Hyg 1999; 60:10-15.

10. Cone RA. Mucus. In: Orga PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, eds. Mucosal Immunology. New York: Academic Press, 1999:43-60.

11. Kraehenbuhl JP, Neutra MR. Molecular and cellular basis of immune protection of mucosal surfaces. Physiol Rev 1992; 72:853-879.

12. Savage DC. Microbial ecology of the gastrointestinal tract. Ann Rev Microbiol 1977; 6:155-178.

13. Alexander M. Microbial Ecology. New York: Wiley, 1971 pp. 3-21.

14. Nord CE, Hermdah IA, Kager L. Antimicrobial induced alteration of the human oropharyngeal and intestinal microflora. Scand J Infect Dis Suppl 1986; 49:64-72.

15. Trenschel R, Peceny R, Runde V, et al. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination. Bone Marrow Transplant 2000; 26:993-997.

16. Tannock GW. Normal Microflora: An Introduction to Microbes Inhabiting the Human Body. U.K.: Chapman and Hall, 1995.

17. Herbert MK, Holzer P, Roewer N. Problems of the Gastrointestinal Tract in Anesthesia, the Perioperative Period, and Intensive Care. New York; Berlin: Springer, 1999.

18. Cohen MB, Giannella RA. Bacterial infections: pathophysiology, clinical features and treatment. In: Philips SF, Permberton JH, Shorter RG, eds. The Large Intestine: Physiology, Pathophysiology and Disease. New York: Raven Press, 1991:395-428.

19. Conway PL. Microbial ecology of the human large intestine. In: Gibson GR, Macfarlane GT, eds. Human Colonic Bacteria: Nutrition, Physiology, and Pathology. Boca Raton: CRC, 1995:1-24.

20. Stark PL, Lee A. The microbial ecology of the large bowel of the breast-fed and formula-fed infants during the first year of life. J Med Microbiol 1982; 15:189-203.

21. Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol 1996; 4:430-435.

22. Ofek I, Doyle R. Recent developments in bacterial adhesion to animal cells. In: Ofek I, Doyle R, eds. Bacterial Adhesion to Cells and Tissues. London: Chapman and Hall, 1994:321-512.

23. Lee YK, Lim CY, Teng WL, Ouwehand AC, Tuomola EM, Salminen S. Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with Enterobacteria. Appl Environ Microbiol 2000; 66:3692-3697.

24. Mirelman D, Ofek I. Microbial lectins and agglutinins. In: Mirelman D, ed. Microbial Lectins and Agglutinins. New York: J. Wiley and Sons, 1986:1-19.

25. Abraham SM, Sharon N, Ofek I. Adhesion of bacteria to mucosal surfaces. In: Orga PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, eds. Mucosal Immunology. New York: Academic Press, 1999:31-42.

26. Schembri MA, Kjaergaard K, Sokurenko EV, Klemm P. Molecular charcterisation of the Escherichia coli FimH adhesion. J Infect Dis 2001; 183:S28-S31.

27. Adlerberth I, Ahrne S, Johansson ML, Molin G, Hanson LA, Wold AE. A mannose-specific adherence mechanism in Lactobacillusplantarum conferring binding to the human colonic cell line HT-29. Appl Environ Microbiol 1996; 62:2244-2251.

28. Neesen J-R, Granato D, Rouvet M, Servin A, Teneberg S, Karlsson K-A. Lactobacillus johnsonii La1 shares carbohydrates-binding specificities with several enteropathogenic bacteria. Glycobiology 2000; 10:1193-1199.

29. Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35:483-489.

30. Chauviere G, Coconnier MH, Kerneis S, Darfeuille-Michaud A, Joly B, Servin AL. Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus. FEMS Microbiol Lett 1992; 70:213-217.

31. Gopal PK, Prasad J, Smart J, Gill HS. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int J Food Microbiol 2001; 67:207-216.

32. Tuomola EM, Ouwehand AC, Salminen SJ. The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol Med Microbiol 1999; 26:137-142.

33. Busscher HJ, Weerkamp AH. Specific and non-specific interactions in bacterial adhesion to solid substrata. FEMS Microbiol Rev 1987; 46:165-173.

34. Pimentel GC, McClellan AL. In: Freeman WH, ed. The Hydrogen Bond. San Francisco; New York: Reinhold Pub. Corp, 1960.

35. Reid G, Servin AL, Bruce AW, Busscher HJ. Adhesion of three lactobacillus strains to human urinary and intestinal epithelial cells. Microbios 1993; 75:57-65.

36. Klemm P. Fimbrial adhesions of Escherichia coli. Rev Infect Dis 1985; 7:321-340.

37. Adlerberth I. Establishment of a normal intestinal microflora in the newborn infant. In: Hanson L, Yolken RH, eds. Probiotics, Other Nutritional Factors, and Intestinal Microflora. Philadelphia: Vevey/Lippincott-Raven Publishers, 1999:63-78.

38. Duguid JP, Old DC. Adhesive properties of enterobacteriaceace. In: Beachey EC, ed. In: Bacterial Adherence, Receptors and Recognition, Vol. 6. London: Chapman and Hall, 1980:185-216.

39. He F, Ouwehan AC, Hashimoto H, Isolauri E, Benno Y, Salminen S. Adhesion of Bifidobacterium spp. to human intestinal mucus. Microbiol Immunol 2001; 45:259-262.

40. Kirjavainen PV, Ouwehand AC, Isolauri E, Salminen SJ. The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol Lett 1998; 167:185-189.

41. He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2001; 30:43-47.

42. Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 1995; 61:3202-3207.

43. Lee YK, Ho PS, Low CS, Arvilommi H, Salminen S. Permanent colonization by Lactobacillus casei is hindered by low rate of cell division in mouse gut. Appl Environ Microbial 2004; 70:670-674.

44. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 1994; 10:55-63.

45. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995; 78:491-497.

46. Haller D, Blum S, Bode Ch, Hammes WP, Schiffrin EJ. Activation of human PBMC by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun 2000; 68:752-759.

47. Anton P, O' Conell J, O'Conell D, et al. Mucosal binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP). Gut 1998; 42:374-379.

48. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-2088.

49. Takeuchi O, Sato S, Horiuchi T, et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002; 169:10-14.

50. Gerwitz AT, Simon PO, Jr., Schmitt CK, et al. Salmonella typhimurium translocates flagellin across intestinal epithelia inducing a proinflammatory response. J Clin Invest 2001; 107:99-109.

51. Di Martino P, Girardeau JP, Der Vartanian M, Joly B, Darfeuille-Michaud A. The central variable V2 region of the CS31A major subunit is involved in the receptor-binding domain. Infect Immun 1997; 65:609-616.

52. Backhed F, Hornef M. Toll-like receptor 4-mediated signaling by epithelial cell surfaces: necessity or threat? Microbes Infect 2003; 5:951-959.

53. Abreu MT, Arnold ET, Thomas LS, et al. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 2002; 277:20431-20437.

54. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412:346-351.

55. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K. The kinase TAK1 can activate the NIK-I kappa B as well as MAP kinase cascade in the IL-1 signaling pathway. Nature 1999; 398:252-256.

56. Delhase M, Hayawaka M, Chen Y, Karin M. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphoryation. Science 1999; 284:309-313.

57. Hu Y, Baud V, Delhase M, et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 1999; 284:316-320.

58. Zhang Y, Bliska JB. Role of toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection. Infect Immun 2003; 71:1513-1519.

59. Radel SJ, Genco RJ, De Nardin E. Structural and functional characterization of the human formyl peptide receptor ligand-binding region. Infect Immun 1994; 62:1726-1732.

60. Snyderman R, Fudman EJ. Demonstration of a chemotactic factor receptor on macrophages. J Immunol 1980; 124:2754-2757.

61. Chaudhary PM, Ferguson C, Nguey V, et al. Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for multi-gene receptor family in human. Blood 1998; 91:4020-4027.

62. Gewirtz AT, Liu Y, Sitareman SV. Madara. Intestinal epithelial pathobiology: past, present, future. Best Pract Res Clin Gastroenterol 2002; 16:851-867.

63. Lu L, Walker WA. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr 2001; 73:1124S-1130S.

64. Luo Y, Frey EA, Pfuetzner RA, et al. Crystal structure of enteropathogenic Escherichia coli intimin-receptor complex. Nature 2000; 405:1073-1077.

65. Sinclair J, O' Brien AA. Cell surface-localized nucleolin is a eukaryotic receptor for the adhesion intimin-g of enterohemorrhagic Escherichia coli O157: H7. J Biol Chem 2002; 277:2876-2885.

66. Jonsson H, Ström E, Ross S. Addition of mucin to the growth medium triggers mucus-binding activity in different strains of Lactobacillus reuteri in vitro. FEMS Microbiol Lett 2001; 204:19-22.

67. Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in't Veld JHJ. Overview of gut flora and probiotics. Int J Food Microbiol 1998; 41:85-101.

68. Hooper LV, Xu J, Falk PG, Midtvedt T, Gordon JI. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci U.S.A. 1999; 96:9833-9838.

69. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000; 1:113-118.

Pregnancy And Childbirth

Pregnancy And Childbirth

If Pregnancy Is Something That Frightens You, It's Time To Convert Your Fear Into Joy. Ready To Give Birth To A Child? Is The New Status Hitting Your State Of Mind? Are You Still Scared To Undergo All The Pain That Your Best Friend Underwent Just A Few Days Back? Not Convinced With The Answers Given By The Experts?

Get My Free Ebook

Post a comment